Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Turning Point Therapeutics, Inc. | SVP & General Counsel | Common Stock | 0 | $76.00 | Aug 17, 2022 | Direct | |
Turning Point Therapeutics, Inc. | SVP & General Counsel | Stock Option (right to buy) | 0 | Aug 17, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TPTX | Turning Point Therapeutics, Inc. | Aug 17, 2022 | 2 | -$3.42M | 4 | Aug 17, 2022 | SVP & General Counsel |
TPTX | Turning Point Therapeutics, Inc. | Apr 11, 2022 | 2 | $0 | 4 | Apr 12, 2022 | SVP & General Counsel |
TPTX | Turning Point Therapeutics, Inc. | Apr 11, 2022 | 0 | $0 | 3 | Apr 12, 2022 | SVP & General Counsel |